Novinky

Generic Drug Prices Rise When Market Competition Drops

Generic drug price increases are strongly linked to market competition, according to data published online July 3 in the Annals of Internal Medicine. Viac >>

 

Latest Data Shows the Need to Promote Biosimilar and Value Added Medicines for Better Health

Recognising that biosimilar medicines can vastly improve access to biological medicines, the IGBA has produced a wealth of new material to better inform patients, physicians and governments on the science that underpins these important therapies and benefits that they bring. Viac >>

 

62% of Medicines Dispensed in Europe are Generic, according to IMS New Data

Public health: new IMS data reveals the growing importance of generic medicines for public health as they now account for 62% of medicines dispensed in Europe delivering huge value while impacting only 4% of total healthcare budgets. Viac >>

 

Ingrid Schwarzenberger, new Chair of the IGBA Biosimilars Committee

IGBA is pleased to announce today the nomination of Ingrid Schwarzenberger, Head Global Regulatory Affairs at Sandoz Biopharmaceuticals, as the new Chair of the IGBA Biosimilars Committee Viac >>

 

Indukovaná preskripcia

Polemika v časopise Lekárnik. Viac >>

 

Príde lieková agentúra k nám?

Európska lieková agentúra v Londýne sa kvôli brexitu musí presídliť do iného štátu EÚ. Prejavilo o ňu záujem viacero krajín vrátane Slovenska. Viac >>

 

Prídeme vďaka emergentnému systému o kategorizované lieky?

Ak lekáreň požadovaný liek nemá a nevie ho objednať od distribútora štandardnou cestou, cez emergentný systém vypíše anonymizovaný recept. Viac >>

 

Zamotaný kruh s liekmi

Vďaka referencovaniu má Slovensko jedny z najnižších cien liekov a zdravotníckych pomôcok v EÚ Viac >>

 

«zobraziť 1 z 2 strán»